Development of a new cancer biomarker assay

January 14, 2013 at 4:16 pm Leave a comment

The Centers for Disease Control and Prevention estimates that one in every four deaths in the United States is due to cancer, (and presumably the statistics are the same for Canada), yet approximately one-third of all cancer cases could be prevented if detected early enough. Bio-Rad has recently developed the Bio-Plex Pro human cancer biomarker panel 2, which employs a magnetic bead-based workflow to quantify cancer biomarkers in diverse matrices including serum, plasma, cell culture supernatant and many other sample types.

Read “Development and Validation of Bio-Plex Pro Huaman Cancer Biomarker Panel 2” to learn more.

Entry filed under: Bio-Plex Technotes, Bio-Rad Product Highlight. Tags: , .

Sitting @ Work: A New Perspective for Employee Wellness Canadian Biotechnology News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


biorad1

Bio-Rad Canada has sponsored the development of this site to advance the productivity of the Canadian Biotechnology sector and the fine people who work in it across the country.  We invite readers to contribute content: posters, tools, research and presentations, articles white papers, multimedia, music downloads and entertainment, conference announcements, videos. Please contact info@cbt20.ca for more information.

Bookmark and Share

Site developed by What If What Next(TM)

Follow us on Twitter


%d bloggers like this: